HBI
61
11
PVH
43
-2
PNC
63
-2
LNC
43
-2
VFC
42
-3
CB
57
3
ADBE
60
3
WMT
67
5
STT
67
-4
OKE
52
6
MU
55
-4
TDC
62
3
HRL
45
12
BBY
41
-2
GS
70
-2
CINF
56
2
CLX
48
3
A
48
-2
ILMN
49
-2
PPL
67
3
HBI
61
11
PVH
43
-2
PNC
63
-2
LNC
43
-2
VFC
42
-3
CB
57
3
ADBE
60
3
WMT
67
5
STT
67
-4
OKE
52
6
MU
55
-4
TDC
62
3
HRL
45
12
BBY
41
-2
GS
70
-2
CINF
56
2
CLX
48
3
A
48
-2
ILMN
49
-2
PPL
67
3
Financhill
Back

Phathom Pharmaceuticals Vs. Lixte Biotechnology Holdings Industry Stock Comparison

Sell
30

PHAT
Phathom Pharmaceuticals

Last Price:
$4.24
Seasonality Move:
10.29%
Sell
20

LIXT
Lixte Biotechnology Holdings

Last Price:
$1.17
Seasonality Move:
15.27%
Sell
30
Phathom Pharmaceuticals (PHAT) is a Sell

Is Phathom Pharmaceuticals a Buy, Sell or Hold?

  • The current Phathom Pharmaceuticals [PHAT] share price is $4.25. The Score for PHAT is 30, which is 40% below its historic median score of 50, and infers higher risk than normal.
  • PHAT is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
20
Lixte Biotechnology Holdings (LIXT) is a Sell

Is Lixte Biotechnology Holdings a Buy, Sell or Hold?

  • The current Lixte Biotechnology Holdings [LIXT] share price is $1.17. The Score for LIXT is 20, which is 60% below its historic median score of 50, and infers higher risk than normal.
  • LIXT is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing an extreme reading that indicates risk could be especially high.

PHAT Stock Price Chart

What is Phathom Pharmaceuticals's stock price today?

  • The Phathom Pharmaceuticals share price today is $4.25
    The current trend is relatively stagnant and PHAT is experiencing buying pressure, which is a positive indicator for future bullish movement.

LIXT Stock Price Chart

What is Lixte Biotechnology Holdings's stock price today?

  • The Lixte Biotechnology Holdings share price today is $1.17
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and LIXT is experiencing selling pressure, which indicates risk of future bearish movement.

PHAT Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.05 Buy
Relative Strength Index (14 RSI): 54.82 Buy
Chaikin Money Flow: 716455 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (2.93 - 4.33) Buy
Bollinger Bands (100): (3.92 - 6.52) Sell

LIXT Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0 Buy
Relative Strength Index (14 RSI): 41.23 Sell
Chaikin Money Flow: -6300 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (1.21 - 1.37) Sell
Bollinger Bands (100): (1.04 - 2.1) Sell

PHAT Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 4.16 Buy
20-day SMA: 3.53 Buy
50-day SMA: 4.38 Sell
200-day SMA: 9.44 Sell
8-day EMA: 4.11 Buy
20-day EMA: 3.93 Buy
50-day EMA: 4.34 Sell
200-day EMA: 7.48 Sell

LIXT Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 1.29 Sell
20-day SMA: 1.3 Sell
50-day SMA: 1.26 Sell
200-day SMA: 1.73 Sell
8-day EMA: 1.28 Sell
20-day EMA: 1.29 Sell
50-day EMA: 1.32 Sell
200-day EMA: 1.75 Sell

Phathom Pharmaceuticals Earnings Growth & PHAT Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.92 per share, an increase next quarter of $0.37 per share, an increase this year of $1.80 per share, and an increase next year of $2.44 per share.

Lixte Biotechnology Holdings Earnings Growth & LIXT Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Phathom Pharmaceuticals Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Lixte Biotechnology Holdings Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):